FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

Sunday, May 21, 2023 - 14:30 in Health & Medicine

Evusheld was designed to protect immunocompromised people from serious cases of COVID-19, but the latest Omicron variants have rendered the drug useless.

Read the whole article on LA Times - Science

More from LA Times - Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net